Brady Corporation — Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended April 30, 2024; comparable periods ended April 30, 2023. Amounts below are in millions unless noted.
Business context and results
Brady manufactures identification solutions and workplace safety products. It reports two geographic segments: Americas & Asia and Europe & Australia.
| Metric | Three months 2024 | Three months 2023 | Nine months 2024 | Nine months 2023 |
|---|---|---|---|---|
| Net sales | $343.4 | $337.1 | $998.0 | $985.9 |
| Gross margin | $177.0 | $169.7 | $510.8 | $481.4 |
| Gross margin % | 51.6% | 50.3% | 51.2% | 48.8% |
| Operating income | $63.5 | $63.0 | $177.2 | $163.2 |
| Operating margin | 18.5% | 18.7% | 17.8% | 16.5% |
| Net income | $50.9 | $48.1 | $141.8 | $125.5 |
| Diluted EPS, Class A | $1.05 | $0.96 | $2.91 | $2.51 |
Material changes and operating performance
- Third-quarter sales rose 1.9%; organic sales grew 4.5%, offset in part by a 2.3% divestiture impact and 0.3% unfavorable currency. Nine-month sales rose 1.2%, with 3.0% organic growth and 0.6% favorable currency, partly offset by a 2.4% divestiture impact.
- Gross margin improved in both periods, primarily from organic growth in higher-margin product lines. Operating income rose 0.9% in the quarter and 8.6% year to date; the prior-year period included a $3.8 million gain on the PremiSys business sale.
- R&D and SG&A spending increased, including investment in sales, technology, and R&D personnel and digital advertising. Management said higher headcount and R&D investment supported product development and growth initiatives.
- Americas & Asia nine-month sales declined 0.5%, as organic growth was offset by divestitures; segment profit increased 9.9%. Europe & Australia sales increased 4.7% and segment profit increased 8.5%.
Cash flow, balance sheet, and liquidity
- Nine-month operating cash flow was $171.1 million, versus $129.9 million; management attributed the increase mainly to improved profitability, lower inventory spending, and lower annual incentive payments.
- Investing cash outflow was $70.3 million, primarily reflecting purchase of a previously leased facility in Mexico and construction costs in Belgium. Capital expenditures were $69.2 million.
- Financing cash outflow was $89.0 million, including $72.2 million of treasury-share purchases and $33.9 million of dividends. Cash increased $8.9 million to $160.5 million.
- At April 30, 2024, long-term debt was $63.8 million. The company reported $234.5 million available under its credit agreement, potentially expandable to $1,084.5 million subject to conditions. Management cited total available liquidity of $1,245.0 million, including cash.
- The credit agreement matures November 14, 2027. Brady was in compliance with its covenants; reported debt-to-EBITDA and interest-coverage ratios were 0.2x and 98.1x, respectively. Approximately 97% of cash was held outside the United States.
Outlook, risks, and notable items
- No specific sales or earnings guidance was provided. Management expects inflationary pressures, supply-chain disruptions, and other business disruptions to continue through the end of fiscal 2024; raw-material and labor inflation are expected to persist. It said pricing and efficiency gains had helped mitigate these pressures.
- The company expects its ongoing annual income tax rate to be approximately 21%, based on its current business mix and tax laws.
- Risks identified include lower product demand, raw-material cost increases or shortages, supply-chain disruption, foreign-currency movements, cybersecurity threats, competition, acquisition integration, litigation, and regulatory or geopolitical developments. Management reported no material change to previously disclosed risk factors.
- Brady said ordinary-course legal proceedings are not expected to have a material adverse effect; the filing does not provide a clear quantified estimate of potential exposure. A May 20, 2024 dividend declaration set a $0.235-per-share payment for July 31, 2024.
- The exhibit list includes a March 15, 2024 put option letter with MML Capital Europe VI II S.A. and other holders; the supplied filing text does not describe its terms or financial impact.
Important facts for investors to verify
- Whether organic growth and gross-margin gains continue, particularly across the two reportable segments.
- How the planned facility investments affect capital spending, cash conversion, and future operating capacity.
- Availability and conditions of the credit agreement’s potential increase, and the effects of foreign-held cash and any repatriation taxes.
- The terms and potential implications of the put option letter, which are not explained in the provided filing text.
- Progress on inflation, supply-chain, currency, cybersecurity, and other identified risks; no quantified forward sales or earnings outlook was provided.